H268Q (p.His268Gln) variant of LPL (Lipoprotein lipase)
H268Q (p.His268Gln) in LPL (Lipoprotein lipase) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as conflicting interpretations in the context of Hyperlipoproteinemia, type I. The available variant effect predictions contribute to a CATVariant prioritization score of 0.12 / 1. The record also includes population frequency data and published literature.
H268Q (p.His268Gln) variant details
- p.His268Gln
- rs776585907
- ClinGen CA370468990
- ClinVar RCV001262712
- ExAC rs776585907
- Conflicting interpretations
- Hyperlipoproteinemia, type I
- Missense
- Variant Prioritization Score for Impact Estimate 0.116
- CADD 6.91
- PolyPhen-2 0.99
- SIFT 0.01
- ClinVar: Conflicting classifications of pathogenicity (Hyperlipoproteinemia, type I)
- EBI: Likely benign
- UniProt: Likely benign
- Most common in the Non-Finnish European population (allele frequency 9e-07)
- Cited in: Evaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guideline. (PMID 22962670)
- Cited in: Lipoprotein Lipase Deficiency. (PMID 20301485)